Oncology Institute Inc (The)
TOI
Get informed when a big investor buys or sells
+ FollowMarket Cap$468.92M
Close$
$-0.05
101.2% downside
Current Fair Value
101.2% downsideOvervalued by 101.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $468.92 Million |
|---|---|
| Enterprise Value | $464.89 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.54 |
| Beta | 0.36 |
| Outstanding Shares | 1,018,016,090 |
Return
| Return on Equity | 267.20% |
|---|---|
| Return on Assets | -25.87% |
| Return on Invested Capital | -41.34% |
Valuation & Multiples
| P/E Ratio | -109.73 |
|---|---|
| PEG | 125.72 |
| Price to Sales | - |
| Price to Book Ratio | -4.23 |
| Enterprise Value to Revenue | 0.85 |
| Enterprise Value to EBIT | -12.65 |
| Enterprise Value to Net Income | -11 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | -1.61 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 13, 2026
EPS Estimate
$-0.07
Average shareholder expectationRevenue Estimate
$143.35 M
Average shareholder expectationNext Earnings Call
Expected Date
August 12, 2026
EPS Estimate
$-0.07
Average shareholder expectationRevenue Estimate
$157.10 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0653▲ 4.75% |
|---|---|
| Total Calls | 2,425,900▼ 34.11% |
| Total Puts | 158,300▲ 142.79% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 4.20%▲ 0.25% |
|---|---|
| Total Invested | $118.92M▼ 13.27% |
| Investors Holding | 120▼ 2.00% |
ESG Score
No data